NCCAM Exec Says CAM Dosing Studies Needed Before Clinical Trials
This article was originally published in The Tan Sheet
Executive Summary
The National Center for Complimentary & Alternative Medicine at NIH should conduct more preclinical research before investing in Phase II clinical trials, NCCAM Deputy Director Margaret Chesney, PhD, recommends